Skip to main content
Clinical Trials/NCT03424993
NCT03424993CompletedPhase 4

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure: Dietary Counseling Study

University of Delaware2 sites in 1 country100 target enrollmentStarted: January 21, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
100
Locations
2
Primary Endpoint
Reflected Pulse Wave Amplitude

Study Overview

Brief Summary

The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Detailed Description

Cardiovascular disease remains a major Public Health problem and is the leading cause of death in the US. Dietary sodium restriction is considered an important lifestyle modification for individuals with hypertension; however, there is controversy about the effects of dietary salt given that many individuals do not have "salt sensitive" blood pressure. Deleterious effects of salt on the vasculature may explain the finding that chronic DSR reduces the cardiovascular event rate by 25%despite only minor reductions in BP. It is not known whether dietary sodium restriction improves central pulsatile hemodynamics, known to be related to the development of left ventricular hypertrophy and heart failure risk, and whether the hypothesized improvements in central hemodynamics are similar in men & women. The purpose of this study is to determine the effects of dietary sodium restriction through dietary counseling on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Habitual dietary sodium intake > 3400mg per day

Exclusion Criteria

  • Abnormal resting ECG
  • Current abnormal blood panel (assessed by comprehensive metabolic panel, lipid panel and complete blood count).
  • Hypertension (currently taking anti-hypertensive medications or resting blood pressure >140/90 mmHg)
  • Medical history of cardiovascular disease, malignant cancer, diabetes or kidney disease
  • Obesity (Body Mass Index > 30)
  • Current pregnancy
  • Unable to provide consent

Outcomes

Primary Outcomes

Reflected Pulse Wave Amplitude

Time Frame: Change from baseline at 4 weeks

Late systolic pulsatile load on the left ventricle represented by reflected pulse wave amplitude; assessed by echocardiography combined with applanation tonometry.

Secondary Outcomes

  • Conduit Artery Endothelial Dependent Dilation(Change from baseline at 4 weeks)
  • Microvascular Function(Change from baseline at 4 weeks)
  • Arterial Stiffness(Change from baseline at 4 weeks)
  • Forward pulse wave amplitude(Change from baseline at 4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

William Farquhar

Professor

University of Delaware

Study Sites (2)

Loading locations...

Similar Trials